Back | Next |
home / stock / okyo / okyo message board
Subject | By | Source | When |
---|---|---|---|
$OKYO The gaining up | Sirpeter | investorshub | 10/01/2023 2:52:56 AM |
what do you make of this data? | Pisd | investorshub | 10/01/2023 1:33:03 AM |
must see | mfayman | investorshub | 10/01/2023 1:20:16 AM |
Price now | Count Crypto | investorshub | 10/01/2023 1:19:45 AM |
Price now last up | Count Crypto | investorshub | 10/01/2023 12:17:39 AM |
Hows a going? $OKYO looks interesting | Anita Dump | investorshub | 09/30/2023 8:15:52 PM |
short squeeze article | Count Crypto | investorshub | 09/30/2023 8:12:22 PM |
$OKYO are we finally gonna see some action | Sirpeter | investorshub | 09/30/2023 7:51:30 PM |
Good news recently, we should start to see this one move | mfayman | investorshub | 09/30/2023 6:13:57 PM |
Looks like we're primed for that next leg | mfayman | investorshub | 09/30/2023 6:01:12 PM |
$OKYO What do you make of this? | StocksNcash | investorshub | 09/30/2023 3:46:08 PM |
$OKYO Have a look at this | Sirpeter | investorshub | 09/30/2023 2:46:17 PM |
Absolutely there will definitely be more opportunities ahead imo | mfayman | investorshub | 09/30/2023 2:15:19 PM |
Price now | StocksNcash | investorshub | 09/30/2023 2:01:18 PM |
bulls and bears | mfayman | investorshub | 09/30/2023 1:24:36 PM |
$OKYO here we go bulls news is here | Count Crypto | investorshub | 09/30/2023 12:38:31 PM |
$OKYO short squeeze | StocksNcash | investorshub | 09/30/2023 11:47:42 AM |
$OKYO what does this mean? | Ryguy008 | investorshub | 09/30/2023 11:25:30 AM |
Agreed | Count Crypto | investorshub | 09/30/2023 11:24:26 AM |
Same here | Count Crypto | investorshub | 09/30/2023 11:24:11 AM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- OKYO Pharma Ltd CEO Gary Jacobs joined Steve Darling from Proactive to share additional key findings from the Phase 2 clinical trial evaluating the safety and efficacy of OK-101 (0.05%) ophthalmic solution in patients with dry eye disease (DED). This trial involved 240 pat...
LONDON and NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases ...
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment disease...